pharmaphorum

AI firm Generate signs $1bn discovery deal with Novartis

Flagship Pioneering-backed artificial intelligence start-up Generate:Biomedicines has attracted another big pharma partnership, this time with Novartis. The wide-ranging deal, worth up to $1 billion, ...
FierceBiotech

Generate raises $273M—$100M less than previous round—but a huge bounty

Flagship Pioneering-founded Generate Biomedicines is tacking on a gigantic $273 million in series C funds, though the haul didn't reach the heights of the biotech’s previous $370 million raise back in ...
FierceBiotech

Flagship-founded Generate snags $370M to generate medicines based on proteins, the 'building blocks of life'

Generate Biomedicines wants to get in on the lucrative world of protein-based therapeutics, which comprise about 7 in 10 new drug approvals. The Flagship Pioneering-founded biotech got a major boost ...
GEN

Generate:Biomedicines Raises Largest Biotech Series C of 2023

When Molly Gibson, PhD, left her position as Kaleido Biosciences’ leader of computational biology and joined Flagship Pioneering in 2017, she had been mulling over the question of what the main ...
Business Wire

Generate Capital Converts to a Public Benefit Corporation

SAN FRANCISCO--(BUSINESS WIRE)--Generate, a leading sustainable infrastructure investment and operating platform, today announced its official conversion to a Public Benefit Corporation (PBC). Since ...